Definition: DIC is characterized by widespread intravascular clotting and bleeding.
Causes: It is commonly initiated by endothelial damage or the release of tissue factor.
Pathophysiology:
Excess thrombin is generated, leading to widespread clotting.
Results in ischemia, infarction, and necrosis of tissues.
Overwhelms clotting factors, continuing the cycle of bleeding.
Common Situations: Frequently occurs alongside severe sepsis and septic shock.
Injury Response:
Endothelial damage and tissue factor release activate the intrinsic and extrinsic pathways of coagulation.
Massive thrombin release prompts intravascular coagulation.
Consequences:
Leads to vascular occlusion and tissue ischemia.
Increased consumption of clotting factors and activation of the fibrinolytic pathway causes diffuse bleeding.
Complications:
Initial inflammatory response prompts clotting, followed by fibrinolysis.
Depletion of platelets occurs due to their consumption in clot formation.
Bleeding: Development of bleeding as a significant manifestation of DIC.
Platelet Count: Decreased.
Fibrinogen Level: Decreased.
PTT: Increased sensitivity.
PT: Increased sensitivity.
D-Dimer: Elevated levels.
Fibrin Split Products (FSP): Elevated.
Focus: Must concentrate on identifying and treating the underlying cause.
If infection is present, administer antibiotics.
Bleeding Management:
Fresh Frozen Plasma (FFP) and platelets are given to replenish clotting factors.
Low-dose heparin may be utilized to balance for pathway deficiencies.
Continuous assessment of all body systems is essential due to the widespread impact of DIC.
Implement bleeding precautions during patient care.
Lab Monitoring: Regular checks on BUN, creatinine, arterial blood gases (ABG), urine analysis, and hemoccult tests.
Description: Present before pregnancy or diagnosed before 20 weeks gestation.
Continuation: Persists beyond 42 days postpartum.
Criteria: Systolic BP > 140 mmHg and diastolic BP > 90 mmHg.
Description: Onset occurs after 20 weeks gestation, resolving within 12 weeks postpartum.
Features: SBP > 140 mmHg and DBP > 90 mmHg without proteinuria.
Diagnosis: Conducted retrospectively if transient.
Definition: A significant condition during pregnancy indicating maternal vasospasm and possible hypoperfusion to the fetus.
Symptoms: May include headache, visual disturbances, and hyperreflexia.
Connection to DIC: Associated vascular endothelial damage can lead to DIC.
Mild Preeclampsia: BP > 140/90 mmHg, proteinuria 300 mg/24 hr.
Severe Preeclampsia: BP > 160/110 mmHg, proteinuria > 500 mg/24 hr.
Eclampsia: Causes seizures, with marked proteinuria.
Antepartum: Emphasizes bed rest, frequent BP checks, daily weight, and urine protein monitoring.
Intrapartum: Requires continuous fetal monitoring.
Postpartum: Patients generally improve rapidly after delivery, though seizures can still occur for up to 48 hours post-delivery.
Effects: Increased risk for small gestational age (SGA), sedation at birth.
Hypermagnesemia: Related to maternal magnesium sulfate treatment.
Strategies:
Promote bed rest, monitor vital signs, and restrict sodium intake.
Administer magnesium sulfate, frequent BP monitoring required.
Immediate Care: Emergent delivery may be necessary if fetal distress is present.
Definition: Stands for hemolysis, elevated liver enzymes, and low platelets.
Association: Recognized as a complication in conditions like preeclampsia and eclampsia, often presenting in the third trimester.
Symptoms: Severe right upper quadrant pain, nausea, and liver distention related to DIC.
Common Medications: Include Magnesium Sulfate, Calcium Gluconate, Hydralazine, Labetalol, and Nifedipine.
Dosing: Must follow specific protocols to ensure safety and effectiveness.
Watch for:
Headaches, visual changes, decreased urine output, and weight gain.
Elevate BP readings indicating potential complications.
Definition: Characterized by seizures or coma during pregnancy in patients showing signs of preeclampsia.
Monitoring Needs: Keen observation for fetal hypoxia and possible complications such as cerebral hemorrhage.